Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-087033
Filing Date
2021-06-29
Accepted
2021-06-29 20:44:42
Documents
2
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120930-4_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2120930-4_3seq1.xml 3 3784
2 EXHIBIT 24 tm2120930d4_ex24.htm EX-24 9205
  Complete submission text file 0001104659-21-087033.txt   14392
Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40544 | Film No.: 211059980

Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations